Angio Scan

Write a Review
3.00 LBS
  • Angio Scan
  • Angio Scan


Early diagnosis of cardiovascular disease (CVD) is the main area of our research and development.

Our company develops and commercializes new noninvasive methods for early diagnosis of cardiovascular disease and for monitoring of the effectiveness of cardiovascular therapies. Our primary focus is early diagnosis of atherosclerosis.

Этапы развития атеросклероза

Our company has developed and is offering several diagnostic products “Angioscan”. These systems assess the health of blood vessels and detect the risk of cardiovascular disease several years before any clinical manifestations of the disease.

Our diagnostic solutions include products for Medical Professionals and for home use by consumers. We have developed and received certifications for several models of our diagnostic systems: a dual-channel device Angioscan-01 for Medical Professionals, a single-channel device Angioscan-01M, which can be used in both clinical and home settings, and a portable device Angioscan-01P for personal/home use.

Below is a list of diseases and conditions, whose diagnosis is aided by Angioscan products:

  • Arterial Hypertension
  • Heart Failure
  • Coronary Arterial Disease
  • Diabetes
  • Atherosclerosis of cerebral blood vessels and those of lower extremities
  • High risk of stroke and heart attack
  • Certain forms of erectile dysfunction

 A non-invasive test with our products takes 5 minutes and includes the following:

  1. An assessment of several parameters of cardiovascular health:An assessment of the level of stress and the health of baro-receptor sensor system
    • Stiffness of arterial wall
    • Elasticity of aorta
    • Central arterial blood pressure
    • Endothelial function in small (resistive) and large (conductive) arteries
    • Ability of endothelial cells to produce nitric oxide, as a measure of protection against atherosclerosis
    • Analysis of pulse wave shape (amplitude and timing of early and late systolic waves)
    • Augmentation index (effect of the reflected wave)
  2. An evaluation of biological age of the vascular system
  3. Monitoring the effectiveness of cardiovascular therapies
  4. A respiration test
  5. An assessment of the risk of developing cardiovascular disease
  6. An evaluation of the risk of kidney dysfunction and/or endothelial dysfunction in the third trimester of pregnancy

 Cardiovascular disease often develops without any symptoms and is undetected until it is far advanced. Heart attack or stroke is often the first manifestation of atherosclerosis in patients who have not had any prior symptoms of the disease. This fact highlights the importance of developing new technologies for early diagnosis in patients at high risk for cardiovascular disease.


Angioscan products identify patients, whose early-stage cardiovascular disease is undetected by the existing diagnostic methods, and direct their physicians to prescribe cardiovascular therapies at the time when such interventions are most effective.

 The current cardiovascular diagnostic tools assess risk factors (high blood pressure, elevated cholesterol levels, etc.) and detect atherosclerotic plaque (by coronary angiography, stress testing, etc.). However, the diagnosis of the risk factors in a patient provides no information about the early pathological changes in his blood vessels; and, by the time atherosclerotic plaque is detected, the disease is already well advanced. The current diagnostic approaches segment all adults based on their CVD risk: high, medium and low. In the USA, for instance, the medium risk adults comprise one-third of the population. In order to provide targeted therapy to such individuals, more granular clinical information about the CVD risk is needed.

 Early detection of cardiovascular disease, by assessing arterial stiffness and endothelial dysfunction, provides physicians with detailed and clinically valuable information, and, as was shown in a number of clinical studies, helps identify patients at high risk for cardiovascular disease.

 In Russian Federation, mortality due to cardiovascular disease remains high at 57% of all deaths or 2.4 million cases over the last two years. Moreover, nearly 20% of all CVD patients die before reaching 55 years of age. Since atherosclerosis is the main cause of cardiovascular disease, and it often develops undetected, the only way to significantly reduce the impact of atherosclerosis on public health is to diagnose the disease early and to prevent the progression of the disease with therapies. Hence, new diagnostics of early stages of atherosclerosis, such as Angioscan products, are addressing one of the most important areas of public health – prevention and treatment of CVD.

 AngioScan-01M is a simplified version of AngioScan-01. Unlike AngioScan-01, AngioScan-01M does not take an occlusive test for assessment of endothelial function. All other functions of the products are identical.

 The installation of AngioScan Professional in necessary for operating under PC control (Windows). The professional models of the devices assess all parameters of cardiovascular health, that includes also the following:

 pulse rate;

  • augmentation index;
  • analysis of pulse wave shape;
  • biological age of the vascular system;
  • stiffness of arterial wall;
  • reflected wave index;
  • ejection duration;
  • amplitude and timing of early and late systolic waves;
  • central arterial pressure;
  • stress index and other parameters.

 In addition, AngioScan-01 assets the following parameters:

 phase occlusion index;

  • amplitude occlusion index.

 The test results are kept at a PC database. The medical personnel can conduct researches on test results on any computer with AngioScan Professional software installed, as the data of tests can be easily exchanged between computers.

 Graphical interface AngioScan Professional allows to conduct a detailed test either of every pulse wave or chosen group of pulse waves. The conclusion of cardiovascular system assessment is based on test results. It is displayed in textual form and can be printed out. 

View AllClose

Disclaimer/Warning: Statements expressed within this site have not been evaluated by the Food and Drug Administration. Any and all information and/or statements found within this site are for educational purposes only and are NOT intended to diagnose, treat, cure, prevent disease or replace the advice of a licensed healthcare practitioner. Note this website may contain links to other websites and information operated by other parties. These links are provided for your convenience and reference only. Great Solutions LLC is not responsible for the content or products of any linked site or the links contained therein. Beth Campbell is a lay health advisor and teacher who deals strictly in helping people to improve their general health and fitness through better nutrition, improved lifestyle, health habits, and positive mental attitudes. Great Solutions, LLC and affiliates are not licensed physicians and cannot diagnose diseases, prescribe drugs, or recommend treatments for specific disease conditions and they do not dispense medical advice. Beth Campbell is ordained and licensed as Minister of Health and has the authority to dispense Monastic Medicine to all the people through the American University of Indigenous Medicine in accordance with the provisions of law & order codes and as authorized by resolution NR2016.2014. Some Products and services are available to Private Network Members Only. The Network was declared and established under Canon Law and purposed to bring practitioners and healers together to preserve the orthodoxy of sacred healing. The license stands as notice such that it is manifest that a “non-Network jurisdiction for a rule in question” is accepted in regard to the licensed practitioner. The American University of Indigenous Medicine provides education for it’s practitioners to practice and research wellness programs through the four ancient traditions of natural and sacred healing which cover indigenous, monastic, holistic and/or dynastic healing. Any views and ideas expressed are not intended to be a substitute for conventional medical advice or service. By using this website and clicking on any product or link you agree to the Terms and Conditions and to the Refund Policy on this website. You also agree that no responsibility or liability will be incurred to any person or entity with respect to any loss, damage, or injury caused or alleged to be caused directly or indirectly by the information or links contained within this site or to any link on this website. If you have a severe medical condition, please see a licensed healthcare practitioner.

*Weight loss results can vary depending on the individual. There is no guarantee of specific results. This website does not provide medical advice. The information, including but not limited to, text, graphics, images and other material, contained on this website is for educational purposes only. Results May Vary: Causes for being overweight or obese vary from person to person. No individual result should be seen as typical. Whether genetic or environmental, it should be noted that food intake, rates of metabolism and levels of exercise and physical exertion vary from person to person. This means weight loss results will also vary from person to person. The content is not intended in any way as a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website. 23 Years in Business Est. 1997 - Over 24,000 Satisfied Customers


The Website content has been reviewed for FDA and
FTC regulation compliance by The Vitamin Lawyer.*